Multi-Morbidity and Polypharmacy in Older People: Challenges and Opportunities for Clinical Practice
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Multi-morbidity and polypharmacy are common in older people and pose a challenge for health and social care systems, especially in the context of global population ageing. They are complex and interrelated concepts in the care of older people that require early detection and patient-centred shared decision making underpinned by multi-disciplinary team-led comprehensive geriatric assessment (CGA) across all health and social care settings. Personalised care plans need to remain responsive and adaptable to the needs and wishes of the patient, enabling the individual to maintain their independence. In this review, we aim to give an up-to-date account of the recognition and management of multi-morbidity and polypharmacy in the older person.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clegg, A., Young, J., Iliffe, S., Rikkert, M. O., & Rockwood, K. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62167-9 · Cited by 9,503
Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60240-2 · Cited by 6,972 · cited 2×
“The proportion of patients living with multi-morbidity is likely to climb as life expectancy continues to rise [6] and is fast becoming a global health problem [14–16].”
BackgroundVos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
SANRA—a scale for the quality assessment of narrative review articles
Baethge, C., Goldbeck-Wood, S., & Mertens, S. (2019) · Research Integrity and Peer Review · doi:10.1186/s41073-019-0064-8 · Cited by 3,469 · cited 4×
“We applied the principles from the Scale for the Assessment of Narrative Review Articles (SANRA) to this manuscript.”
MethodInfluentialAdverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Pirmohamed, M., James, S., Meakin, S., Green, C., Scott, A. K., Walley, T. J., Farrar, K., Park, B. K., & Breckenridge, A. M. (2004) · BMJ · doi:10.1136/bmj.329.7456.15 · Cited by 3,230 · cited 1×
“5%, with ADR directly leading to acute admission in 80% of cases [40].”
BackgroundAging with multimorbidity: A systematic review of the literature
Marengoni, A., Angleman, S., Melis, R., Mangialasche, F., Karp, A., Garmen, A., Meinow, B., & Fratiglioni, L. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.03.003 · Cited by 3,092
STOPP/START criteria for potentially inappropriate prescribing in older people: version 2
O'Mahony, D., O'Sullivan, D., Byrne, S., O'Connor, M. N., Ryan, C., & Gallagher, P. (2014) · Age and Ageing · doi:10.1093/ageing/afu145 · Cited by 2,397
Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O’Reilly, D. S. J., Haffner, S. M., Isles, C., Macfarlane, P. W., Packard, C. J., Cobbe, S. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000080897.52664.94 · Cited by 1,506 · cited 1×
“Interaction between these diseases leads to a worsening of each individual condition, as well as an increased risk of cardiovascular events such as stroke or myocardial infarction [19,20].”
BackgroundJournal of the American Geriatrics Society
(1976) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1976.tb03307.x · Cited by 1,313
Hu, G. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.10.1066 · Cited by 1,135 · cited 1×
“Interaction between these diseases leads to a worsening of each individual condition, as well as an increased risk of cardiovascular events such as stroke or myocardial infarction [19,20].”
BackgroundHealth, functioning, and disability in older adults—present status and future implications
Chatterji, S., Byles, J., Cutler, D., Seeman, T., & Verdes, E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61462-8 · Cited by 1,074
Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management
Dent, E., Morley, J. E., Cruz-Jentoft, A. J., Woodhouse, L., Rodríguez-Mañas, L., Fried, L. P., Woo, J., Aprahamian, I., Sanford, A., Lundy, J., et al. (2019) · The Journal of nutrition, health and aging · doi:10.1007/s12603-019-1273-z · Cited by 1,049
Multimorbidity and quality of life in primary care: a systematic review
Fortin, M., Lapointe, L., Hudon, C., Vanasse, A., Ntetu, A. L., & Maltais, D. (2004) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-2-51 · Cited by 963
The anticholinergic risk scale and anticholinergic adverse effects in older persons
Rudolph, J. L. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.106 · Cited by 835 · cited 1×
“Older people are more susceptible to anticholinergic side effects from commonly prescribed drugs such as amitriptyline, oxybutynin, cetirizine, and mirtazapine, which include delirium, reduced cognition, gait and balance problems, constipation, urinary retention, and dry mouth [56].”
BackgroundFrailty and Multimorbidity: A Systematic Review and Meta-analysis
Vetrano, D. L., Palmer, K., Marengoni, A., Marzetti, E., Lattanzio, F., Roller-Wirnsberger, R., Lopez Samaniego, L., Rodríguez-Mañas, L., Bernabei, R., Onder, G., et al. (2019) · The Journals of Gerontology: Series A · doi:10.1093/gerona/gly110 · Cited by 788 · cited 1×
“A recent meta-analysis of 78,122 participants of 48 studies found that, on average, seven out of ten adults living with frailty were also multi-morbid [32].”
BackgroundMultimorbidity and mortality in older adults: A systematic review and meta-analysis
Nunes, B. P., Flores, T. R., Mielke, G. I., Thumé, E., & Facchini, L. A. (2016) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2016.07.008 · Cited by 767 · cited 1×
“08) increased risk of dying respectively, compared to those who were not multi-morbid [13].”
BackgroundAdverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes
Davies, E. C., Green, C. F., Taylor, S., Williamson, P. R., Mottram, D. R., & Pirmohamed, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004439 · Cited by 692 · cited 1×
“In a follow up study of hospital wards, it was estimated that one in seven patients experienced an ADR that contributed to health deterioration and increased the length of hospital stay [41].”
BackgroundGlobal Multimorbidity Patterns: A Cross-Sectional, Population-Based, Multi-Country Study
Garin, N., Koyanagi, A., Chatterji, S., Tyrovolas, S., Olaya, B., Leonardi, M., Lara, E., Koskinen, S., Tobiasz-Adamczyk, B., Ayuso-Mateos, J. L., et al. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv128 · Cited by 635
Adapting clinical guidelines to take account of multimorbidity
Guthrie, B., Payne, K., Alderson, P., McMurdo, M. E. T., & Mercer, S. W. (2012) · BMJ · doi:10.1136/bmj.e6341 · Cited by 530 · cited 1×
“Whilst this is sometimes necessary, treating diseases in isolation can lead to the duplication of efforts as well as fragmented, poorly coordinated healthcare assessments without adequate responsibility, accountability, and follow up [23,24].”
BackgroundCare Patterns in Medicare and Their Implications for Pay for Performance
Pham, H. H., Schrag, D., O'Malley, A. S., Wu, B., & Bach, P. B. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa063979 · Cited by 511
Hughes, L. D., McMurdo, M. E. T., & Guthrie, B. (2013) · Age and Ageing · doi:10.1093/ageing/afs100 · Cited by 506 · cited 7×
“This causes uncertainty regarding the potential risks and benefits of starting evidence-based medications for an older patient in the context of their multi-morbidity and invariably leads to additional treatment burden, lower adherence, and increased risk of ADR [31].”
BackgroundInfluentialAdverse drug reactions in elderly patients
Routledge, P. A., O'Mahony, M. S., & Woodhouse, K. W. (2004) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01875.x · Cited by 476 · cited 1×
“Advanced age in itself should not be a reason for withholding effective therapies [39].”
BackgroundAvery, A. J., Rodgers, S., Cantrill, J. A., Armstrong, S., Cresswell, K., Eden, M., Elliott, R. A., Howard, R., Kendrick, D., Morris, C. J., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61817-5 · Cited by 454
Understanding how we age: insights into inflammaging
Baylis, D., Bartlett, D. B., Patel, H. P., & Roberts, H. C. (2013) · Longevity & Healthspan · doi:10.1186/2046-2395-2-8 · Cited by 411
Self-citationNew horizons in multimorbidity in older adults
Yarnall, A. J., Sayer, A. A., Clegg, A., Rockwood, K., Parker, S., & Hindle, J. V. (2017) · Age and Ageing · doi:10.1093/ageing/afx150 · Cited by 361
Afshar, S., Roderick, P. J., Kowal, P., Dimitrov, B. D., & Hill, A. G. (2015) · BMC Public Health · doi:10.1186/s12889-015-2008-7 · Cited by 345
Muth, C., Blom, J. W., Smith, S. M., Johnell, K., Gonzalez‐Gonzalez, A. I., Nguyen, T. S., Brueckle, M. ‐., Cesari, M., Tinetti, M. E., & Valderas, J. M. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12842 · Cited by 339
Masoudi, F. A., Havranek, E. P., Wolfe, P., Gross, C. P., Rathore, S. S., Steiner, J. F., Ordin, D. L., & Krumholz, H. M. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00189-3 · Cited by 334
The Age‐Friendly Health System Imperative
Fulmer, T., Mate, K. S., & Berman, A. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15076 · Cited by 314 · cited 2×
“The process is iterative and the key to its success is timely review and coordination so that the care plan generated from a CGA remains responsive to the patient’s needs [24,46,66,69,70].”
BackgroundComorbidity Profile of Dementia Patients in Primary Care: Are They Sicker?
Schubert, C. C., Boustani, M., Callahan, C. M., Perkins, A. J., Carney, C. P., Fox, C., Unverzagt, F., Hui, S., & Hendrie, H. C. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.00543.x · Cited by 285 · cited 1×
“Further examples relevant for older people are congestive cardiac failure and dementia—where individuals often have several co-existent long-term conditions such as diabetes and hypertension and have impairments in activities of daily living (ADL) and physical function [21].”
BackgroundMultimorbidity Patterns in Primary Care: Interactions among Chronic Diseases Using Factor Analysis
Prados-Torres, A., Poblador-Plou, B., Calderón-Larrañaga, A., Gimeno-Feliu, L. A., González-Rubio, F., Poncel-Falcó, A., Sicras-Mainar, A., & Alcalá-Nalvaiz, J. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032190 · Cited by 282 · cited 1×
“Health conditions have a tendency to cluster and interact with other related diseases and can worsen the severity of each disease or result in the development of a further potentially more serious condition [17].”
BackgroundPayne, R. A., Abel, G. A., Guthrie, B., & Mercer, S. W. (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.121349 · Cited by 280
Deprescribing in Frail Older People: A Randomised Controlled Trial
Potter, K., Flicker, L., Page, A., & Etherton-Beer, C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149984 · Cited by 246
Hanlon, J. T., & Schmader, K. E. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0118-4 · Cited by 242
Fabbri, E., An, Y., Zoli, M., Simonsick, E. M., Guralnik, J. M., Bandinelli, S., Boyd, C. M., & Ferrucci, L. (2015) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu127 · Cited by 240 · cited 3×
“This is undoubtedly a cause for celebration, but the challenge posed by cumulative demographic changes of such magnitude require immediate action from multi-disciplinary teams to provide patient-centred and age-friendly health and social care [3,4].”
BackgroundClinical assessment and management of multimorbidity: summary of NICE guidance
Farmer, C., Fenu, E., O’Flynn, N., & Guthrie, B. (2016) · BMJ · doi:10.1136/bmj.i4843 · Cited by 238
Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?
Calderón-Larrañaga, A., Poblador-Plou, B., González-Rubio, F., Gimeno-Feliu, L. A., Abad-Díez, J. M., & Prados-Torres, A. (2012) · British Journal of General Practice · doi:10.3399/bjgp12x659295 · Cited by 236
Prevalence of polypharmacy in a Scottish primary care population
Payne, R. A., Avery, A. J., Duerden, M., Saunders, C. L., Simpson, C. R., & Abel, G. A. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1639-9 · Cited by 210 · cited 1×
“1% received ten or more medications [35].”
Damarell, R., Morgan, D. D., & Tieman, J. (2020) · BMC Family Practice · doi:10.1186/s12875-020-01197-8 · Cited by 195
Newell, S., & Jordan, Z. (2015) · JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-2015-1072 · Cited by 187 · cited 1×
“In this regard, patient-centred or patient priority care that accounts for the patient’s preferences, needs, and values ensures that patients or their appointed attorneys guide clinical decision making [48].”
BackgroundSergi, G., De Rui, M., Sarti, S., & Manzato, E. (2011) · Drugs & Aging · doi:10.2165/11592010-000000000-00000 · Cited by 184
Methods to reduce prescribing errors in elderly patients with multimorbidity
O'Mahony, D., Gallagher, P., & Lavan, A. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s80280 · Cited by 184 · cited 1×
“Polypharmacy, defined as the concurrent use of at least 4–5 medications rises considerably as the number of health problems and healthcare service use increases [33,34].”
BackgroundDeprescribing: What Is It and What Does the Evidence Tell Us?
Thompson, W., & Farrell, B. (2013) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v66i3.1261 · Cited by 173 · cited 1×
“GPs are in an ideal position to make shared decisions with patients and families to prescribe, deprescribe, rationalise, and optimise medications but need funded time and space to nurture long-lasting, trustful therapeutic partnerships [53,63,64].”
BackgroundUnderstanding and improving multidisciplinary team working in geriatric medicine
Ellis, G., & Sevdalis, N. (2019) · Age and Ageing · doi:10.1093/ageing/afz021 · Cited by 171 · cited 1×
“The process is iterative and the key to its success is timely review and coordination so that the care plan generated from a CGA remains responsive to the patient’s needs [24,46,66,69,70].”
BackgroundPatient Priority–Directed Decision Making and Care for Older Adults with Multiple Chronic Conditions
Tinetti, M. E., Esterson, J., Ferris, R. E., Posner, P., & Blaum, C. S. (2016) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2016.01.012 · Cited by 159 · cited 3×
“The process is iterative and the key to its success is timely review and coordination so that the care plan generated from a CGA remains responsive to the patient’s needs [24,46,66,69,70].”
BackgroundExternal validity of randomized controlled trials in COPD
Travers, J., Marsh, S., Caldwell, B. O., Williams, M., Aldington, S., Weatherall, M., Shirtcliffe, P., & Beasley, R. W. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.10.011 · Cited by 147
Saunders, C., Byrne, C. D., Guthrie, B., Lindsay, R. S., McKnight, J. A., Philip, S., Sattar, N., Walker, J. J., Wild, S. H., & on behalf of the Scottish Diabetes Research Network Epidemiology Group (2013) · Diabetic Medicine · doi:10.1111/dme.12047 · Cited by 122
Approaches to the diagnosis and prevention of frailty
Woolford, S. J., Sohan, O., Dennison, E. M., Cooper, C., & Patel, H. P. (2020) · Aging Clinical and Experimental Research · doi:10.1007/s40520-020-01559-3 · Cited by 116 · cited 1×
“The process is iterative and the key to its success is timely review and coordination so that the care plan generated from a CGA remains responsive to the patient’s needs [24,46,66,69,70].”
BackgroundSelf-citationBoyd, C. M., Vollenweider, D., & Puhan, M. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041601 · Cited by 109
Poly-de-prescribing to treat polypharmacy: efficacy and safety
Garfinkel, D. (2017) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098617736192 · Cited by 102
Consideration of Multiple Chronic Diseases in Randomized Controlled Trials
Jadad, A. R. (2011) · JAMA · doi:10.1001/jama.2011.1886 · Cited by 98
How are drug regimen changes during hospitalisation handled after discharge: a cohort study
Viktil, K. K., Blix, H. S., Eek, A. K., Davies, M. N., Moger, T. A., & Reikvam, A. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001461 · Cited by 94 · cited 1×
“Several studies have also found that the number of medications increased after hospital admission with the prescription of two additional drugs on average [36,37].”
BackgroundMultimorbidity and Its Impact on Workers: A Review of Longitudinal Studies
Cabral, G. G., de Souza, A. C. D., Barbosa, I. R., Jerez‐Roig, J., & de Souza, D. L. B. (2019) · Safety and Health at Work · doi:10.1016/j.shaw.2019.08.004 · Cited by 85
Tinetti, M., Dindo, L., Smith, C. D., Blaum, C., Costello, D., Ouellet, G., Rosen, J., Hernandez-Bigos, K., Geda, M., & Naik, A. (2019) · PLOS ONE · doi:10.1371/journal.pone.0218249 · Cited by 78 · cited 1×
“when considering holistic management of the patient [24,46,47].”
BackgroundCentenarian Studies: Important Contributors to Our Understanding of the Aging Process and Longevity
Willcox, D. C., Willcox, B. J., & Poon, L. W. (2010) · Current Gerontology and Geriatrics Research · doi:10.1155/2010/484529 · Cited by 78 · cited 1×
“This is undoubtedly a cause for celebration, but the challenge posed by cumulative demographic changes of such magnitude require immediate action from multi-disciplinary teams to provide patient-centred and age-friendly health and social care [3,4].”
BackgroundUsing the NO TEARS tool for medication review
Lewis, T. (2004) · BMJ · doi:10.1136/bmj.329.7463.434 · Cited by 75
Deprescribing Is an Essential Part of Good Prescribing.
Farrell, B. J., & Mangin, D. A. (2019) · PubMed · Cited by 71
Challenges of deprescribing in the multimorbid patient
Cullinan, S., Hansen, C. R., Byrne, S., O’Mahony, D., Kearney, P. M., & Sahm, L. J. (2016) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2016-000921 · Cited by 68
Liacos, M., Page, A. T., & Etherton‐Beer, C. (2020) · Australian Prescriber · doi:10.18773/austprescr.2020.033 · Cited by 59
Principle of rational prescribing and deprescribing in older adults with multiple chronic conditions
Ouellet, G. M., Ouellet, J. A., & Tinetti, M. E. (2018) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098618791371 · Cited by 59 · cited 1×
“Examples include anti-hypertensives drugs used to treat hyperlipidaemia and osteoporosis treatments [57,58].”
BackgroundLaws, M. B., Bezreh, Taubin, Rifkin, D. E., & Wilson, I. B. (2011) · Patient Preference and Adherence · doi:10.2147/ppa.s25971 · Cited by 45 · cited 1×
“These factors affect adherence, and studies suggest that up to 50% of prescribed medications may not be taken by older people [62].”
BackgroundNew horizons in deprescribing for older people
Woodford, H. J., & Fisher, J. M. (2019) · Age and Ageing · doi:10.1093/ageing/afz109 · Cited by 45 · cited 1×
“Examples include anti-hypertensives drugs used to treat hyperlipidaemia and osteoporosis treatments [57,58].”
BackgroundChamberlain, A. M., Rutten, L. J. F., Jacobson, D. J., Fan, C. L., Wilson, P. M., Rocca, W. A., Roger, V. L., & Sauver, J. L. S. (2019) · Journal of Comorbidity · doi:10.1177/2235042x19873486 · Cited by 44 · cited 1×
“Patients such as these who are multi-morbid and have functional limitations can experience the poorest health outcome from the inability to self-manage chronic long-term conditions as well as the ensuing polypharmacy [22].”
BackgroundGP‐Led Deprescribing in Community‐Living Older Australians: An Exploratory Controlled Trial
Anderson, K., Freeman, C. R., Foster, M. M., & Scott, I. A. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16273 · Cited by 43
Vermunt, N. P. C. A., Elwyn, G. J., Westert, G. P., Harmsen, M., Rikkert, M. G. M. O., & Meinders, M. J. (2019) · BMC Family Practice · doi:10.1186/s12875-019-0966-z · Cited by 40 · cited 1×
“The process is iterative and the key to its success is timely review and coordination so that the care plan generated from a CGA remains responsive to the patient’s needs [24,46,66,69,70].”
BackgroundPolypharmacy – we make it worse! A cross‐sectional study from an acute admissions unit
Betteridge, T., Frampton, C. M., & Jardine, D. L. (2012) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2011.02690.x · Cited by 34 · cited 1×
“Several studies have also found that the number of medications increased after hospital admission with the prescription of two additional drugs on average [36,37].”
BackgroundInclusion of Older Adults in Research: Ensuring Relevance, Feasibility, and Rigor
Kuchel, G. A. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15802 · Cited by 33
External Validity of Randomized Controlled Trials in Severe Asthma
Pahus, L., Alagha, K., Sofalvi, T., Vachier, I., BOURDIN, A. A., Molinari, N., & Chanez, P. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201502-0391le · Cited by 27
Laursen, J. T., Kornholt, J., Betzer, C., Petersen, T. S., & Christensen, M. (2018) · Health Services Research and Managerial Epidemiology · doi:10.1177/2333392818792169 · Cited by 27
Lea, S. C., Watts, K., Davis, N. A., Panayiotou, B., Bankart, M. J., Arora, A., & Chambers, R. M. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015278 · Cited by 13
O'Mahony, M. S., & Parbhoo, A. (2020) · British Journal of Hospital Medicine · doi:10.12968/hmed.2019.0213 · Cited by 12
Cited by
Prevalence of multimorbidity and polypharmacy among adults and older adults: a systematic review
Nicholson, K., Liu, W., Fitzpatrick, D., Hardacre, K. A., Roberts, S., Salerno, J., Stranges, S., Fortin, M., & Mangin, D. (2024) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(24)00007-2 · Cited by 263
Pathophysiology and treatment of osteoporosis: Challenges for clinical practice in older people
Barnsley, J., Buckland, G., Chan, P. E., Ong, A., Ramos, A. S., Baxter, M., Laskou, F., Dennison, E. M., Cooper, C., & Patel, H. P. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-01817-y · Cited by 199
Self-citation
Metadata
- Authors
- Aggarwal, P., Woolford, S. J., & Patel, H. P.
- Venue
- Geriatrics
- Publisher
- MDPI AG
- Published
- 2020-10-28
- Volume
- 5
- Issue
- 4
- Pages
- 85
- ISSN
- 2308-3417 (ISSN-L)
- OpenAlex
- W3081999921
- Cited by
- 231
- References
- 71
- FWCI
- 6.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.